Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
IndustryAugust 19, 2026

Trump Nominates Overton to Lead FDA

President Trump has nominated Heidi Overton, MD, currently deputy director of the White House Domestic Policy Council and a veteran of the America First think tank, to serve as FDA Commissioner. The nomination requires Senate confirmation. If confirmed, Overton would oversee the agency responsible for drug approvals, safety monitoring, and regulatory oversight affecting Medicaid pharmacy benefits, including biosimilar approvals and drug supply chain policies. The nomination comes as states and managed care plans manage rising prescription drug costs.

Why it mattersFDA leadership influences drug approval timelines, biosimilar availability, and safety policies that directly affect Medicaid pharmacy budgets and formulary management.

Pharmacy

Read the full article at healthcaredive.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.